These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 2578106)

  • 1. Differences in lithium effects in depressed and healthy subjects.
    Rudorfer MV; Karoum F; Ross RJ; Potter WZ; Linnoila M
    Clin Pharmacol Ther; 1985 Jan; 37(1):66-71. PubMed ID: 2578106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of desipramine, zimelidine, electroconvulsive treatment and lithium on rat brain biogenic amines: a comparison with peripheral changes.
    Karoum F; Korpi ER; Chuang LW; Linnoila M; Wyatt RJ
    Eur J Pharmacol; 1986 Mar; 121(3):377-85. PubMed ID: 2422047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of norepinephrine turnover by serotonergic drug in man.
    Rudorfer MV; Scheinin M; Karoum F; Ross RJ; Potter WZ; Linnoila M
    Biol Psychiatry; 1984 Feb; 19(2):179-93. PubMed ID: 6201198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of drugs and electroshock treatment on cerebral monoaminergic systems.
    Barkai AI
    Ann N Y Acad Sci; 1986; 462():147-62. PubMed ID: 2423001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine.
    Asberg M; Ringberger VA; Sjöqvist F; Thorén P; Träskman L; Tuck JR
    Clin Pharmacol Ther; 1977 Feb; 21(2):201-7. PubMed ID: 13959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome.
    Swann AC; Koslow SH; Katz MM; Maas JW; Javaid J; Secunda SK; Robins E
    Arch Gen Psychiatry; 1987 Apr; 44(4):345-54. PubMed ID: 2436590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers.
    Andreou D; Saetre P; Kähler AK; Werge T; Andreassen OA; Agartz I; Sedvall GC; Hall H; Terenius L; Jönsson EG
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):700-4. PubMed ID: 21295953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis.
    Goodwin FK; Post RM
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():299-332. PubMed ID: 769117
    [No Abstract]   [Full Text] [Related]  

  • 9. Circadian and circatrigintan rhythms of biogenic amines in premenstrual syndrome (PMS).
    Odink J; Van der Ploeg HM; Van den Berg H; Van Kempen GM; Bruinse HW; Louwerse ES
    Psychosom Med; 1990; 52(3):346-56. PubMed ID: 1695014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotransmitters in the brains of patients with dementia disorders.
    Gottfries CG
    Dan Med Bull; 1985 Feb; 32 Suppl 1():44-8. PubMed ID: 2580668
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease.
    Vermeiren Y; Van Dam D; Aerts T; Engelborghs S; De Deyn PP
    Neurobiol Aging; 2014 Dec; 35(12):2691-2700. PubMed ID: 24997673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of depression--a critical review.
    Ban TA
    Psychosomatics; 1975; 16(1):17-20. PubMed ID: 1101282
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the changes in central catecholamine systems following short- and long-term lithium treatment and the consequences of lithium withdrawal.
    Ahluwalia P; Singhal RL
    Neuropsychobiology; 1984; 12(4):217-23. PubMed ID: 6152562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamines (norepinephrine, dopamine, serotonin) in the rat medial vestibular nucleus: endogenous levels and turnover.
    Cransac H; Cottet-Emard JM; Pequignot JM; Peyrin L
    J Neural Transm (Vienna); 1996; 103(4):391-401. PubMed ID: 9617784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced actions on brain neurotransmitter systems and changes in the behaviors and emotions of depressed patients.
    Katz MM; Maas JW; Frazer A; Koslow SH; Bowden CL; Berman N; Swann AC; Stokes PE
    Neuropsychopharmacology; 1994 Oct; 11(2):89-100. PubMed ID: 7530963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of lithium on catecholamines, serotonin, and their major metabolites in discrete brain regions.
    Gottberg E; Grondin L; Reader TA
    J Neurosci Res; 1989 Mar; 22(3):338-45. PubMed ID: 2709448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism.
    Carlsson A; Adolfsson R; Aquilonius SM; Gottfries CG; Oreland L; Svennerholm L; Winblad B
    Adv Biochem Psychopharmacol; 1980; 23():295-304. PubMed ID: 6156586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disassociation of carbon disulfide-induced depression of flash-evoked potential peak N166 amplitude and norepinephrine levels.
    Graff JE; Herr DW
    Toxicol Sci; 2003 Jun; 73(2):403-15. PubMed ID: 12700426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biogenic amine/metabolite response during in-flight emergencies.
    Krahenbuhl GS; Harris J; Malchow RD; Stern JR
    Aviat Space Environ Med; 1985 Jun; 56(6):576-80. PubMed ID: 2409957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid.
    Bowden CL; Koslow SH; Hanin I; Maas JW; Davis JM; Robins E
    Clin Pharmacol Ther; 1985 Mar; 37(3):316-24. PubMed ID: 2578912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.